The goal of this randomized clinical trial is to compare clinical and radiological success rates of NeoPutty MTA, ProRoot MTA and TheraCal PT pulpotomy in 4-10 years old healthy pediatric patients. The main question it aims to answer is: Which of these 3 materials are best suited for pulpotomy treatment in the aspect of clinical and radiological success rates. Participants will undergo a pulpotomy treatment in primary molar teeth with one of these materials used.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Clinical Success Of Pulpotomy Treatments Performed With Proroot MTA, NeoPUTTY MTA, TheraCal PT In Primary Teeth
Timeframe: 6 months and 9 months post-treatment
Clinical And Radiological Success Of Pulpotomy Treatments Performed With Proroot MTA, NeoPUTTY MTA, TheraCal PT In Primary Teeths
Timeframe: 6 months and 9 months post-treatment